EP3810626
PCSK9 mótverkandi efnasambönd
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
20.6.2019EP published:
23.7.2025EP application number:
19739801.9
EP translation filed:
22.9.2025Grant published:
15.10.2025EPO information:
European Patent Register
Max expiry date:
19.6.2039Expiry date:
19.6.2026
Title in English:
PCSK9 ANTAGONIST COMPOUNDSLanguage of the patent:
English
Timeline
Today
20.6.2019EP application
23.7.2025EP Publication
22.9.2025Translation submitted
15.10.2025Registration published
19.6.2026Expires
Owner
Name:
Merck Sharp & Dohme LLCAddress:
126 East Lincoln Avenue, Rahway, New Jersey 07065, US
Inventor
Name:
WOOD, Harold, B.Address:
Kenilworth, NJ 07033, US
Name:
JOSIEN, Hubert, B.Address:
Kenilworth, NJ 07033, US
Name:
TUCKER, Thomas, JosephAddress:
West Point, PA 19486, US
Name:
KEREKES, Angela, DawnAddress:
Kenilworth, NJ 07033, US
Name:
TONG, LingAddress:
West Point, PA 19486, US
Name:
WALJI, Abbas, M.Address:
West Point, PA 19486, US
Name:
NAIR, Anilkumar, G.Address:
Kenilworth, NJ 07033, US
Name:
DING, Fa-XiangAddress:
Kenilworth, NJ 07033, US
Name:
BIANCHI, ElisabettaAddress:
600-0040 Pomezia, IT
Name:
BRANCA, DanilaAddress:
600-0400 Pomezia, IT
Name:
WU, ChengweiAddress:
West Point, PA 19486, US
Name:
XIONG, YushengAddress:
Kenilworth, NJ 07033, US
Name:
HA, Sookhee, NicoleAddress:
Kenilworth, NJ 07033, US
Name:
LIU, JianAddress:
Kenilworth, NJ 07033, US
Name:
BOGA, Sobhana, BabuAddress:
Kenilworth, NJ 07033, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862687913 PDate:
21.6.2018Country:
US
Classification
Categories:
C07K 7/06, A61K 38/00, C12N 9/64